Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.44 +3.45 (+31.35%)
As of: Sep 29, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Capital Expenditures (2010 - 2026)

Updated

Iovance Biotherapeutics (IOVA) posted Capital Expenditures of $5.44 million for Q2 2026, down 27.1% from $7.46 million a year earlier and down 17.7% from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Capital Expenditures (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Iovance Biotherapeutics was $32.21 million, up 60.0% year-over-year; for FY2025, it came in at $33.84 million, up 205.7% from FY2024.

  • Annual Capital Expenditures shows a five-year compound annual growth rate of -6.3% (FY2020 to FY2025).
  • In prior years, Iovance Biotherapeutics' Capital Expenditures was $11.07 million in FY2024 (-50.3%), $22.29 million in FY2023 (+9.1%), $20.43 million in FY2022 (-45.6%) and $37.57 million in FY2021 (-19.7%).
  • The Q2 2026 figure stands as the lowest quarterly Capital Expenditures since Q4 2024.
  • On a year-over-year basis, Capital Expenditures increased in five of the last seven quarters, with growth averaging 72.6%.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q3 2025, with growth of 374.0%; the weakest was Q2 2024, with a decline of 95.4%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $6.61 million (Q1 2026), $9.32 million (Q4 2025) and $10.84 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 Iovance Biotherapeutics 4.98 Bn 3.77 Bn 55.72 Mn 5.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.44 Mn
Mar 31, 2026 6.61 Mn
Dec 31, 2025 9.32 Mn
Sep 30, 2025 10.84 Mn
Jun 30, 2025 7.46 Mn
Mar 31, 2025 6.21 Mn
Dec 31, 2024 4.17 Mn
Sep 30, 2024 2.29 Mn
Jun 30, 2024 442,000.00
Mar 31, 2024 4.17 Mn
Dec 31, 2023 3.53 Mn
Sep 30, 2023 3.58 Mn
Jun 30, 2023 9.52 Mn
Mar 31, 2023 5.66 Mn
Dec 31, 2022 3.02 Mn
Sep 30, 2022 1.39 Mn
Jun 30, 2022 4.58 Mn
Mar 31, 2022 11.44 Mn
Dec 31, 2021 7.57 Mn
Sep 30, 2021 9.69 Mn
API Access

Iovance Biotherapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IOVA&period=max&api_key=YOUR_API_KEY